Clinical Trials Browser

INDUSTRY × Saline Solution × Gastrointestinal × Clear all

NCT03221426 2026-03-09

KEYNOTE-585

Phase 3 Completed

1,007 enrolled 25 charts

Gastrointestinal

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

NCT07219459 2025-10-21

GDFATHERHCC01

Phase 2 Not yet recruiting

Gastrointestinal

Carcinoma, Hepatocellular

NCT05394714 2025-09-23

A Phase I, Autologous ex Vivo Expanded and Activated NK Cell, Magicell-NK, Infusion for Colon Cancer Post Resection Study

Phase 1 Recruiting

Gastrointestinal

Colonic Neoplasms

NCT06910514 2025-04-09

Efficacy and Safety of a Solution for Endoscopic Mucosal Resection of Colonic Lesions

Phase 3 Completed

Gastrointestinal

Colonic Neoplasms

NCT04210115 2024-11-15

KEYNOTE 975

Phase 3 Active not recruiting

Gastrointestinal

Adenocarcinoma Of Esophagus, Parkinson Disease 4, Autosomal Dominant Lewy Body, Esophageal Squamous Cell Carcinoma

NCT01956812 2021-08-16

PANCRIT®-1

Phase 3 Terminated

Gastrointestinal

Pancreatic Neoplasms

NCT00614393 2018-08-08

Study of Dalotuzumab (MK-0646) in Combination With Cetuximab and Irinotecan in Metastatic Colorectal Cancer (MK-0646-004)

Phase 2 Completed

558 enrolled 17 charts

Gastrointestinal

Colorectal Neoplasms

NCT00851045 2015-10-12

Ph II Trial of a Novel Anti-angiogenic Agent in Combination With Chemotherapy for the Second-line Treatment of Metastatic Colorectal Cancer

Phase 2 Completed

Gastrointestinal

Colorectal Neoplasms